5-(Trifluoromethyl)pyridin-3-ylboronic acid, 95.0%, 5g

Methyl (2R,4R)-4-((tert-butoxycarbonyl)amino)pyrrolidine-2-carboxylate hydrochloride, 95+%, 250mg

4,4'-Oxydiphthalic acid, 97%, 1g

6-Methylpyridine-2-carboxaldehyde, 95.0%, 25g

4-(6-Chloro-5-fluoropyridin-3-yl)benzaldehyde, 95.0%, 1g

6,7-Dihydro-1H-pyrrolo[3,4-d]pyrimidine-2,4(3H,5H)-dione hydrochloride, 95.0%, 100mg

3-Iodo-1H-pyrazole, 95.0%, 5g

N-[(Trimethylsilyl)methyl]benzylamine>96.0%(GC)(T)5mL

MOZAVAPTAN, 99%, 50mg

(S)-2-(2,6-Dichlorobenzamido)succinic acid, 97%, 1g

3-[(2S)-PIPERIDIN-2-YL]-1-(2,3,4-TRIFLUOROBENZOYL)AZETIDIN-3-OL, 95.0%, 1g

3-Butynoic acid, 98.0%, 25g

Sodium sulphate, min. 99%, pa, ACS, ISO, powdered, 1 kg, plastic packaging.